【其他高分选 092】

BC

PMID: 39904652

IF:23.8

Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study

PMID:39904653

IF:23.8

AI for mammography: making double screen-reading history

PMID:39910592

IF:11.4

Oncometabolite D-2HG drives tumor metastasis and protumoral macrophage polarization by targeting FTO/m(6)A/ANGPTL4/integrin axis in triple-negative breast cancer

PMID:39910569

IF:10.6

Overcoming hypoxia-induced breast cancer drug resistance: a novel strategy using hollow gold-platinum bimetallic nanoshells

PMID:39908983

IF:27.7

Fueling metabolic disruption via FMD to boost chemotherapy in TNBC

PMID:39908165

IF:14.3

Tailoring Tumor Cell Golgi Apparatus-Targeting Self-Assembled Peptide for Effective Immunotherapy via Reshaping MIF-Mediated Immunosuppressive Network

PMID:39908017

IF:10.5

Socioeconomic and Geographic Differences in Mammography Trends Following the 2009 USPSTF Policy Update

PMID:39908003

IF:10.4

Endothelial cell pY397-FAK expression predicts risk of breast cancer recurrences after radiotherapy in SweBCG91-RT cohort

PMID:39905264

IF:33.1

Implantation of engineered adipocytes suppresses tumor progression in cancer models

PMID:39905260

IF:33.1

Quantifying cell divisions along evolutionary lineages in cancer

PMID:39908473

IF:10

Prognostic implications of risk definitions from the monarchE and NATALEE trials

PMID:39914749

IF:14

Lipid dysregulation in triple negative breast cancer: Insights from mass spectrometry-based approaches

PMID:39915000

IF:10.3

UBE2T/CDC42/CD276 signaling axis mediates brain metastasis of triple-negative breast cancer via lysosomal autophagy

PMID:39915006

IF:10.3

SNHG17 Reprograms Energy Metabolism of Breast Cancer by Activating Mitochondrial DNAs Transcription

CRC

PMID:39905540

IF:11.4

EGFR inhibition augments the therapeutic efficacy of the NAT10 inhibitor Remodelin in Colorectal cancer

PMID:39905201

IF:27.8

The lactate receptor HCAR1 drives the recruitment of immunosuppressive PMN-MDSCs in colorectal cancer

PMID:39915446

IF:14.7

ROS-induced cytosolic release of mitochondrial PGAM5 promotes colorectal cancer progression by interacting with MST3

PMID:39919174

IF:11.7

Pioneer factor GATA6 promotes colorectal cancer through 3D genome regulation

PMID:39917727

IF:10.7

Enhancing chemoimmunotherapy for colorectal cancer with paclitaxel and alantolactone via CD44-Targeted nanoparticles: A STAT3 signaling pathway modulation approach

GC

PMID:39908861

IF:10.7

Inhibition of glutathione peroxidase 4 suppresses gastric cancer peritoneal metastasis via regulation of RCC2 homeostasis

PMID:39915770

IF:11.4

Preoperative liquid biopsy transcriptomic panel for risk assessment of lymph node metastasis in T1 gastric cancer

HCC

PMID:39907589

IF:10.9

Positively Charged Nanoplastics Destruct the Structure of the PCK1 Enzyme, Promote the Aerobic Gycolysis Pathway, and Induce Hepatic Tumor Risks

PMID:39905730

IF:12.1

The Deubiquitinase USP28 Maintains the Expression of PPARγ and Its Inactivation Protects Mice from Diet-Induced MASH and Hepatocarcinoma

PMID:39914372

IF:14

GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma

PMID:39916327

IF:12.1

Overcoming Immunotherapy Resistance in Hepatocellular Carcinoma by Targeting Myeloid IL-8/ CXCR2 Signaling

LC

PMID:39904319

IF:10.7

IL-8 contributes to functional diversity of tumor-infiltrating neutrophils: A new target for cancer immunotherapy

PMID:39910394

IF:29.9

Transcriptional regulatory network analysis identifies GRN as a key regulator bridging chemotherapy and immunotherapy response in small cell lung cancer

PMID: 39910069

IF:14.7

Massively parallel variant-to-function mapping determines functional regulatory variants of non-small cell lung cancer

PMID: 39910049

IF:14.7

Brd7 loss reawakens dormant metastasis initiating cells in lung by forging an immunosuppressive niche

PMID: 39909044

IF:11.7

Spatially resolved transcriptomics reveal the determinants of primary resistance to immunotherapy in NSCLC with mature tertiary lymphoid structures

PMID: 39907430

IF:11

Combinatorial in vivo genome editing identifies widespread epistasis and an accessible fitness landscape during lung tumorigenesis

PMID: 39905491

IF:27.7

Multimodal lung cancer theranostics via manganese phosphate/quercetin particle

PMID: 39905260

IF:31.8

Quantifying cell divisions along evolutionary lineages in cancer

PMID: 39912611

IF:15.8

Ionizable Lipids with Optimized Linkers Enable Lung-Specific, Lipid Nanoparticle-Mediated mRNA Delivery for Treatment of Metastatic Lung Tumors

PMID: 39913889

IF:42.1

Missed Opportunity for Sotorasib Dose Optimization